scholarly journals O2-03-01: Fractal analysis of amyloid plaques in Alzheimer's disease patients and mouse models

2009 ◽  
Vol 5 (4S_Part_4) ◽  
pp. P107-P107
Author(s):  
Samir Kumar-Singh ◽  
Daniel Pirici ◽  
Christine Van Broeckhoven
2011 ◽  
Vol 32 (9) ◽  
pp. 1579-1587 ◽  
Author(s):  
Daniel Pirici ◽  
Caroline Van Cauwenberghe ◽  
Christine Van Broeckhoven ◽  
Samir Kumar-Singh

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Clémence Dudeffant ◽  
Matthias Vandesquille ◽  
Kelly Herbert ◽  
Clément M. Garin ◽  
Sandro Alves ◽  
...  

2011 ◽  
Vol 7 ◽  
pp. S311-S311
Author(s):  
Zhizhen Zeng ◽  
Tsing-Bau Chen ◽  
Brett Connolly ◽  
Patricia Miller ◽  
Stacey O'Malley ◽  
...  

2017 ◽  
Vol 13 (7) ◽  
pp. P920-P921
Author(s):  
Clémence Dudeffant ◽  
Matthias Vandesquille ◽  
Marc Dhenain ◽  
Sandro Alves ◽  
Emmanuel Comoy ◽  
...  

2004 ◽  
Vol 51 (3) ◽  
pp. 452-457 ◽  
Author(s):  
Jiangyang Zhang ◽  
Paul Yarowsky ◽  
Marcia N. Gordon ◽  
Giovanni Di Carlo ◽  
Sanjay Munireddy ◽  
...  

2021 ◽  
Author(s):  
Knut Sindre Åbjørsbråten ◽  
Gry H. E. Syverstad Skaaraas ◽  
Céline Cunen ◽  
Daniel M. Bjørnstad ◽  
Kristin M. Gullestad Binder ◽  
...  

Increased astrocytic Ca2+ signaling related to amyloid plaques has been shown in Alzheimer's disease mouse models, but to date no reports have characterized behaviorally induced astrocytic Ca2+ signalling in such mice without the confounding effects of anesthesia. Here, we employ an event-based algorithm to assess astrocytic Ca2+ signals in the neocortex of awake-behaving tg-ArcSwe mice and non-transgenic wildtype littermates while monitoring pupil responses and behavior. We demonstrate an attenuated astrocytic Ca2+ response to locomotion and an uncoupling of pupil responses and astrocytic Ca2+ signalling in 15-months old plaque-bearing mice. This points to a potential decoupling of neuromodulatory activation and astrocytic Ca2+ activity, which may account for some of the cognitive dysfunctions observed in Alzheimer’s disease.


2013 ◽  
Vol 2 (2) ◽  
pp. 129-139 ◽  
Author(s):  
Megan W. Bourassa ◽  
Andreana C. Leskovjan ◽  
Ryan V. Tappero ◽  
Erik R. Farquhar ◽  
Carol A. Colton ◽  
...  

2009 ◽  
Vol 2009 ◽  
pp. 1-8 ◽  
Author(s):  
Celeste A. Roney ◽  
Veera Arora ◽  
Padmakar V. Kulkarni ◽  
Peter P. Antich ◽  
Frederick J. Bonte

Detecting aggregated amyloid peptides (Aβplaques) presents targets for developing biomarkers of Alzheimer's disease (AD). Polymeric n-butyl-2-cyanoacrylate (PBCA) nanoparticles (NPs) were encapsulated with radiolabelled amyloid affinityI125-clioquinol (CQ, 5-chloro-7-iodo-8-hydroxyquinoline) as in vivo probes.I125-CQ-PBCA NPs crossed the BBB (2.3±0.9 ID/g) (P<.05) in the WT mouse (N= 210), compared toI125-CQ (1.0±0.4 ID/g).I125-CQ-PBCA NP brain uptake increased in AD transgenic mice (APP/PS1) versus WT (N= 38;2.54×105±5.31×104 DLU/mm2; versus1.98×105±2.22×104 DLU/mm2) and in APP/PS1/Tau. Brain increases were in mice intracranially injected with aggregated Aβ42peptide (N= 17;7.19×105±1.25×105 DLU/mm2), versus WT (6.07×105±7.47×104 DLU/mm2). Storage phosphor imaging and histopathological staining of the plaques,Fe2+andCu2+, validated results.I125-CQ-PBCA NPs have specificity for Aβin vitro and in vivo and are promising as in vivo SPECT (I123), or PET (I124) amyloid imaging agents.


Sign in / Sign up

Export Citation Format

Share Document